ArticleArchives of virology2026
Characterization of a novel phage BUCT800 against Acinetobacter baumannii and its biofilm removal efficiency.
Article in Archives of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acinetobacter baumannii (A. baumannii) poses a significant global public health threat. As natural antimicrobial agents, phages hold enormous potential for controlling the spread of A. baumannii by targeting environmental pathogens. In this study, we report the isolation and characterization of a novel phage, BUCT800, from wastewater, which specifically lysed ST2-type A. baumannii and forms transparent plaques surrounded by a halo. We analyzed its physiological properties, genomic features, and biofilm removal efficacy. The phage exhibited an optimal MOI of 0.01 and a latent period of about 15 min, and favorable thermal and pH stability. The genome of phage BUCT800 is 42,018 bp in length, with a G + C content of 39%. BLAST analysis showed that it shares the highest similarity with Acinetobacter phage vB_AbaP_APK26, with a query coverage of 89% and a percent identity of 94.72%. Genomic analysis revealed that BUCT800 belonged to the class Caudoviricetes, family Autoscriptoviridae, and did not harbor any known antibiotic resistance or virulence genes. Phage BUCT800 exhibited varying biofilm removal efficiencies against different bacterial strains. Phage BUCT800 at a titer of 1 × 108 PFU/mL removed 72.4% of the T2347 biofilm. Collectively, these findings underscored the substantial potential of phage BUCT800 as an environmental disinfectant.
Indexed as
Identifiers
41963712What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.